Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Midazolam (USL261) for Seizure Clusters
NCT01390220Phase 3Terminated
- Sponsor
- UCB
- Start
- Jun 2011
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of midazolam in seizure cluster, sponsored by UCB. Started Jun 2011; status: terminated.
02
Drugs
midazolam
03
Conditions
seizure cluster
Beyond the preview
Go deeper on NCT01390220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01390220.